Schall, Thomas J.

Schall, Thomas J.
	Affiliated Entities       Chemocentryx, Inc. Immuneering Corp

Add a document

Description
Summary
Document Type	Academic Paper Corporate Document - Internal Corporate Document - Public Court Document Equity Research Government Document - Federal Government Document - State Government Document - Local FBI File Public Records Request Response - FOIA Public Records Request Response - State Non-Profit Report Police Report White Paper
Document Date
Document Source
Source URL
File
	If you would like to be credited for contributing this document, make sure to sign in or sign up first. Once uploaded, your document may not be immediately visible to the public as we review each document for legal issues. Thanks for your patience!

Go Pro to view an analysis and graphs of case roles, types and more.

Filter By From To

	Date Filed	Venue	Case Number	Title	Party Type
	10/8/2003	United States Patent and Trademark Office	10681478	Methods and compositions useful for stimulating an immune re...	Applicant
	10/23/2002	United States Patent and Trademark Office	10279353	Compounds And Methods For Modulating Cxcr3 Function	Applicant
	5/7/2002	United States Patent and Trademark Office	10141508	Methods and compositions for inducing an immune response	Applicant
	2/1/2002	United States Patent and Trademark Office	10061943	Methods And Compositions Useful For Stimulating An Immune Re...	Applicant
	2/1/2002	United States Patent and Trademark Office	10061944	Chemomagnetic retrieval of CMV and CMV infected cells	Applicant
	10/30/2001	United States Patent and Trademark Office	10001221	Compositions For Inducing An Immune Response	Applicant
	8/30/2001	United States Patent and Trademark Office	09944049	Cmv Vaccines	Applicant
	8/30/2001	United States Patent and Trademark Office	09944051	Reagents and methods for the diagnosis of CMV dissemination	Applicant
	8/30/2001	United States Patent and Trademark Office	09944163	Modulators of US 28	Applicant
	4/20/2001	United States Patent and Trademark Office	09839445	Methods and compositions for inducing an immune response	Applicant

10 Rows Total

Outside Counsel (319)

	Last Name	First Name	Middle Name	Firm	Location
	Absher	Alton	L.	Kilpatrick Townsend & Stockton, LLP	Winston-salem, Nc,
	Adams	Scott		Davis Wright Tremaine LLP
	Albert	Philip		Union Bank Bldg
	Alemanni	John	C.	Kilpatrick Townsend & Stockton, LLP	Winston-salem, Nc,
	Ali	Bashir		Brinks Gilson & Lione
	Allen	Kenneth		Steuart St., Tower, One Market Plaza San Fra...	Virginia Beach, VA
	Almeda	Lawrence	G.	Brinks Gilson & Lione
	Aly	Amr	O.	Kilpatrick Townsend & Stockton, LLP	Ny 10036,
	Amanat	Houtan		Kilpatrick Townsend & Stockton, LLP
	Annis	David		Sharp Kabushiki Kaisha
	Apple	Randolph	Ted	Kilpatrick Townsend & Stockton, LLP
	Artuz	Robert		Sharp Kabushiki Kaisha
	Auchterlonie	Thomas		Kilpatrick Townsend & Stockton, LLP
	Ausenhus	Scott		Immunex Corporation
	Babych	Eric		Borg-Warner, Inc.
	Bachman	Jacob		Borg-Warner, Inc.
	Bacoch	John	C.	Brinks Gilson & Lione	Salt Lake City, UT
	Barrish	Mark		Sharp Kabushiki Kaisha
	Basarkar	Girish		Sharp Kabushiki Kaisha
	Bastian	Kevin		Sharp Kabushiki Kaisha
	Baum	Allen		Borg-Warner, Inc.
	Beaupre	Jon		Borg-Warner, Inc.
	Belagodu	Akarsh	P.	Kilpatrick Townsend & Stockton, LLP	Atlanta, GA
	Bennett	Jesse		Kilpatrick Townsend & Stockton, LLP
	Bennett	S.		Borg-Warner, Inc.
	Benson	Joel		Millen, White, Zelano & Braningan, PC
	Berenzweig	Jack		Lione Ltd.
	Bergstrom	James		Sharp Kabushiki Kaisha
	Bernard	Eugene		Sharp Kabushiki Kaisha
	Bertelson	Michael		Digeo, Inc.
	Blackburn	Jennifer		Sharp Kabushiki Kaisha
	Blake	Vanessa		Sharp Kabushiki Kaisha
	Bluestone	David		Borg-Warner, Inc.
	Boring	Landin		Kilpatrick Townsend & Stockton, LLP	Seattle, WA
	Boudreaux	William		Brinks Gilson & Lione
	Bowers	Carl		Kilpatrick Townsend & Stockton, LLP
	Boyd	David		Sharp Kabushiki Kaisha
	Brim	Scott		Borg-Warner, Inc.
	Brinks	Henry		Ltd 99 Percent Working Group
	Britt	Juliene		Perkins Coie LLP	SEATTLE, WA
	Brown	Kyle		Kilpatrick Townsend & Stockton, LLP
	Brown	Theodore		Kilpatrick Townsend & Stockton, LLP
	Burris	Kelly		Borg-Warner, Inc.
	Buschmann	Craig		Brinks Gilson & Lione	Salt Lake City, UT
	Bussey	Megan		Sharp Kabushiki Kaisha
	Calkins	Charles		OFFICE, CHIEF OF ENGINEERS
	Carroll	William		Borg-Warner, Inc.	San Marcos,, CA
	Cassell	Nathan		Sharp Kabushiki Kaisha
	Caswell	Deborah		Glenn Patent Group
	Catmull	Kelvin		Kilpatrick Townsend & Stockton, LLP
	CHANG	KO-FANG		Kilpatrick Townsend & Stockton, LLP
	Chen	Lawrence		Borg-Warner, Inc.
	Choi	Wendy		Kilpatrick Townsend & Stockton, LLP
	Chu	Michael		Borg-Warner, Inc.	Sterling, CO
	Cilella	Magdalena		Brinks Gilson & Lione	Il, IL
	Cleland	James		Borg-Warner, Inc.
	COHEN	ERIC			CHICAGO, IL
	Collins	James		Borg-Warner, Inc.
	Colwell	Robert		PAUL J. WINTERS
	Cook	Roger		Christensen O'Connor Johnson Kindness PLLC
	Copeland	Trevor		Borg-Warner, Inc.
	Cosenza	Martin II		Hauptman Ham, LLP
	Crall	Kristin	Mallatt	Kilpatrick Townsend & Stockton, LLP	Palm City, FL
	Cretsinger	Cathy		Sharp Kabushiki Kaisha
	Curylo	Robert	J.	Kilpatrick Townsend & Stockton, LLP	Atlanta, GA
	Dailey	Robert		Sharp Kabushiki Kaisha
	Daley	William		Sharp Kabushiki Kaisha
	Daniel	Rodney		Borg-Warner, Inc.
	Dare	Heidi		Borg-Warner, Inc.
	Delaney	Timothy		Borg-Warner, Inc.
	DeMille	Rickard		Borg-Warner, Inc.
	Dimino	Michael		Reveo, Inc.
	Dobrowitsky	Margaret		Borg-Warner, Inc.
	Dockrey	Jasper		Borg-Warner, Inc.
	Dodson	Richard		Kilpatrick Townsend & Stockton, LLP
	Doyle	Kristin		Sharp Kabushiki Kaisha
	Dubinsky	Igor		Borg-Warner, Inc.
	Duncan	Jeffery		Antonelli, Terry, Stout & Kraus, LLP
	Durkee	Christopher	M.	Kilpatrick Townsend & Stockton, LLP	Atlanta, GA
	Eberspecher	Kelly		Borg-Warner, Inc.
	Edlavitch	Benjamin		Borg-Warner, Inc.
	Ellenberger	Ernest		Baker Donelson Bearman Caldwell & Berkowitz,...
	Elliott	Allyn		Brinks Gilson & Lione
	Elliott	Joshua		Brinks Gilson & Lione
	Eng	Hugo		Hoffman-La Roche, Inc.
	Eurek	Justin		Kilpatrick Townsend & Stockton, LLP
	Ewing	James	Lindsay	Kilpatrick Townsend & Stockton, LLP	Atlanta, GA
	Feng	Yuezhong		Borg-Warner, Inc.	Il, IL
	Fergan	Robert		Borg-Warner, Inc.
	Ferrario	Matias		Sharp Kabushiki Kaisha
	Flanagan	Lisa		Sharp Kabushiki Kaisha
	Foster	Bryan		Sharp Kabushiki Kaisha
	Fox	Jennifer		Brinks Gilson & Lione
	Frankel	William		Trexler, Bushnell, Giangiorgi, Blackstone & ...
	Franklin	Thomas		Sharp Kabushiki Kaisha
	Freeman	John		Borg-Warner, Inc.
	Gabric	Ralph		Borg-Warner, Inc.
	Gao	Chuan		Kilpatrick Townsend & Stockton, LLP	San Francisco, CA
	Gardner	Jason		Sharp Kabushiki Kaisha
	Gardner	John	Steven	Kilpatrick Townsend & Stockton, LLP	WINSTON-SALEM, NC

319 Rows Total	Page 1 of 4 | Go To

Filter By Form All Records 3 4 5 SC 13G SC 13G/A From To

	Date	Entity	Form Number	Description
	6/13/2024	Immuneering Corp	4	Statement of changes in beneficial ownership of securities
	3/25/2024	Immuneering Corp	4	Statement of changes in beneficial ownership of securities
	3/12/2024	Immuneering Corp	4	Statement of changes in beneficial ownership of securities
	3/12/2024	Immuneering Corp	3	Initial statement of beneficial ownership of securities
	10/24/2022	Chemocentryx, Inc.	4	Statement of changes in beneficial ownership of securities
	8/8/2022	Chemocentryx, Inc.	4	Statement of changes in beneficial ownership of securities
	2/25/2022	Chemocentryx, Inc.	4	Statement of changes in beneficial ownership of securities
	2/14/2022		SC 13G/A
	1/4/2022	Chemocentryx, Inc.	4	Statement of changes in beneficial ownership of securities
	12/3/2021	Chemocentryx, Inc.	4	Statement of changes in beneficial ownership of securities
	3/1/2021	Chemocentryx, Inc.	4	Statement of changes in beneficial ownership of securities
	2/16/2021		SC 13G/A
	1/7/2021	Chemocentryx, Inc.	4	Statement of changes in beneficial ownership of securities
	12/16/2020	Chemocentryx, Inc.	4	Statement of changes in beneficial ownership of securities
	6/16/2020	Chemocentryx, Inc.	4	Statement of changes in beneficial ownership of securities
	5/12/2020	Chemocentryx, Inc.	4	Statement of changes in beneficial ownership of securities
	5/7/2020	Chemocentryx, Inc.	4	Statement of changes in beneficial ownership of securities
	3/5/2020	Chemocentryx, Inc.	4	Statement of changes in beneficial ownership of securities
	2/21/2020	Chemocentryx, Inc.	4	Statement of changes in beneficial ownership of securities
	2/13/2020		SC 13G/A
	2/6/2020	Chemocentryx, Inc.	4	Statement of changes in beneficial ownership of securities
	1/17/2020	Chemocentryx, Inc.	4	Statement of changes in beneficial ownership of securities
	1/3/2020	Chemocentryx, Inc.	4	Statement of changes in beneficial ownership of securities
	11/27/2019	Chemocentryx, Inc.	4	Statement of changes in beneficial ownership of securities
	4/2/2019	Chemocentryx, Inc.	4	Statement of changes in beneficial ownership of securities
	3/6/2019	Chemocentryx, Inc.	4	Statement of changes in beneficial ownership of securities
	2/13/2019		SC 13G/A
	1/14/2019	Chemocentryx, Inc.	4	Statement of changes in beneficial ownership of securities
	1/9/2019	Chemocentryx, Inc.	4	Statement of changes in beneficial ownership of securities
	1/3/2019	Chemocentryx, Inc.	4	Statement of changes in beneficial ownership of securities
	11/9/2018	Chemocentryx, Inc.	4	Statement of changes in beneficial ownership of securities
	7/2/2018	Chemocentryx, Inc.	4	Statement of changes in beneficial ownership of securities
	5/23/2018	Chemocentryx, Inc.	4	Statement of changes in beneficial ownership of securities
	5/17/2018	Chemocentryx, Inc.	4	Statement of changes in beneficial ownership of securities
	5/3/2018	Chemocentryx, Inc.	4	Statement of changes in beneficial ownership of securities
	3/7/2018	Chemocentryx, Inc.	4	Statement of changes in beneficial ownership of securities
	2/13/2018		SC 13G/A
	1/3/2018	Chemocentryx, Inc.	4	Statement of changes in beneficial ownership of securities
	3/2/2017	Chemocentryx, Inc.	4	Statement of changes in beneficial ownership of securities
	2/13/2017		SC 13G/A
	1/4/2017	Chemocentryx, Inc.	4	Statement of changes in beneficial ownership of securities
	3/9/2016	Chemocentryx, Inc.	4	Statement of changes in beneficial ownership of securities
	2/12/2016		SC 13G/A
	2/12/2016		5	Annual statement of changes in beneficial ownership of securitie...
	4/1/2015	Chemocentryx, Inc.	4	Statement of changes in beneficial ownership of securities
	3/27/2015	Chemocentryx, Inc.	4	Statement of changes in beneficial ownership of securities
	3/24/2015	Chemocentryx, Inc.	4	Statement of changes in beneficial ownership of securities
	3/20/2015	Chemocentryx, Inc.	4	Statement of changes in beneficial ownership of securities
	3/18/2015	Chemocentryx, Inc.	4	Statement of changes in beneficial ownership of securities
	2/25/2015	Chemocentryx, Inc.	4	Statement of changes in beneficial ownership of securities

77 Rows Total	Page 1 of 2 | Go To

	Date Recorded	Party	Role	Document Type	Document No.	Invention Title
	4/5/2022	Chemocentryx, Inc.	Assignee	Application Publication	17512335 20220125775	Methods Of Treating Hidradenitis Suppurativa Methods Of Treating Hidradenitis Suppurativa
	4/5/2022	Chemocentryx, Inc.	Assignee	Application Publication Patent	17512335 20220125775 11844790	Methods Of Treating Hidradenitis Suppurativa Methods Of Treating Hidradenitis Suppurativa Methods Of Treating Hidradenitis Suppurativa
	12/20/2021	Chemocentryx, Inc.	Assignee	Application Publication	16990100 20210000834	Treatment Of Focal Segmental Glomerulosclerosis With Ccr2 Antagonists Treatment Of Focal Segmental Glomerulosclerosis With Ccr2 Antagonists
	6/4/2020	Chemocentryx, Inc.	Assignee	Application Publication	16742139 20200289472	Reducing Tumor Burden By Administering Ccr1 Antagonists In Combination W... Reducing Tumor Burden By Administering Ccr1 Antagonists In Combination W...
	1/31/2020	Chemocentryx, Inc.	Assignee	Application Publication	16139745 20190134049	Combination Therapy Using A Chemokine Receptor 2 (ccr2) Antagonist And A... Combination Therapy Using A Chemokine Receptor 2 (ccr2) Antagonist And A...
	1/30/2019	Chemocentryx, Inc.	Assignee	Application Publication	16174658 20190134020	C5aR INHIBITOR REDUCTION OF URINARY sCD163 C5aR INHIBITOR REDUCTION OF URINARY sCD163
	1/29/2019	Chemocentryx, Inc.	Assignee	Application Publication Patent	16156608 20190134042 10758540	Treatment Of Focal Segmental Glomerulosclerosis With Ccr2 Antagonists Treatment Of Focal Segmental Glomerulosclerosis With Ccr2 Antagonists Treatment Of Focal Segmental Glomerulosclerosis With Ccr2 Antagonists
	1/17/2019	Chemocentryx, Inc.	Assignee	Application Publication	15480992 20170290808	Reducing Tumor Burden By Administering Ccr1 Antagonists In Combination W... Reducing Tumor Burden By Administering Ccr1 Antagonists In Combination W...
	1/17/2019	Chemocentryx, Inc.	Assignee	Application Publication Patent	15480992 20170290808 10568870	Reducing Tumor Burden By Administering Ccr1 Antagonists In Combination W... Reducing Tumor Burden By Administering Ccr1 Antagonists In Combination W... Reducing Tumor Burden By Administering Ccr1 Antagonists In Combination W...
	12/22/2006	Chemocentryx, Inc.	Assignee	Application Publication	11496267 20070087986	Compositions and methods for enhancing immunity by chemoattractant adjuv... Compositions and methods for enhancing immunity by chemoattractant adjuv...
	11/30/2005	Chemocentryx, Inc.	Assignee	Application Publication Patent	11198935 20060063223 7572600	Enzymatic Activities In Chemokine-mediated Inflammation Enzymatic Activities In Chemokine-mediated Inflammation Enzymatic Activities In Chemokine-mediated Inflammation
	10/20/2005	Chemocentryx, Inc.	Assignee	Application Publication Patent	11175003 20060034863 8637043	Compositions useful as ligands for the formyl peptide receptor like 1 re... Compositions useful as ligands for the formyl peptide receptor like 1 re... Compositions useful as ligands for the formyl peptide receptor like 1 re...
	1/21/2005	Chemocentryx, Inc.	Assignee	Application Publication Patent	10912638 20050074826 7871619	Compositions And Methods For Detecting And Treating Diseases And Conditi... Compositions And Methods For Detecting And Treating Diseases And Conditi... Compositions And Methods For Detecting And Treating Diseases And Conditi...
	12/6/2004	Chemocentryx, Inc.	Assignee	Application Publication Patent	10912638 20050074826 7871619	Compositions And Methods For Detecting And Treating Diseases And Conditi... Compositions And Methods For Detecting And Treating Diseases And Conditi... Compositions And Methods For Detecting And Treating Diseases And Conditi...
	12/18/2003	Chemocentryx, Inc.	Assignee	Application Publication Patent	10698541 20040170634 7253007	Compositions And Methods For Detecting And Treating Diseases And Conditi... Compositions And Methods For Detecting And Treating Diseases And Conditi... Compositions And Methods For Detecting And Treating Diseases And Conditi...
	12/18/2003	Chemocentryx, Inc.	Assignee	Application Publication Patent	10698541 20040170634 7253007	Compositions And Methods For Detecting And Treating Diseases And Conditi... Compositions And Methods For Detecting And Treating Diseases And Conditi... Compositions And Methods For Detecting And Treating Diseases And Conditi...
	9/24/2003	Chemocentryx, Inc.	Assignee	Application Publication Patent	10452015 20040018563 7413866	Compositions And Methods For Detecting And Treating Diseases And Conditi... Compositions And Methods For Detecting And Treating Diseases And Conditi... Compositions And Methods For Detecting And Treating Diseases And Conditi...
	2/19/2003	Chemocentryx, Inc.	Assignee	Application Publication Patent	10245850 20030124628 7442512	Compositions And Methods For Detecting And Treating Diseases And Conditi... Compositions And Methods For Detecting And Treating Diseases And Conditi... Compositions And Methods For Detecting And Treating Diseases And Conditi...
	11/25/2002	Chemocentryx, Inc.	Assignee	Application Publication Patent	10233326 20030149055 7101894	Bicyclic Compounds As Inhibitors Of Chemokine Binding To Us28 Bicyclic Compounds As Inhibitors Of Chemokine Binding To Us28 Bicyclic Compounds As Inhibitors Of Chemokine Binding To Us28
	11/25/2002	Chemocentryx, Inc.	Assignee	Application Publication Patent	10233336 20030114423 6821998	Arylamines As Inhibitors Of Chemokine Binding To Us28 Arylamines As Inhibitors Of Chemokine Binding To Us28 Arylamines As Inhibitors Of Chemokine Binding To Us28
	10/3/2002	Chemocentryx	Assignee	Application Publication	10141508 20030215460	Methods and compositions for inducing an immune response Methods and compositions for inducing an immune response
	8/19/2002	Chemocentryx, Inc.	Assignee	Application Publication	10141620 20030096260	Compositions useful as ligands for the formyl peptide receptor like 1 re... Compositions useful as ligands for the formyl peptide receptor like 1 re...
	7/8/2002	Chemocentryx	Assignee	Application Publication Patent	10001221 20030108515 7361329	Compositions For Inducing An Immune Response Compositions For Inducing An Immune Response Compositions For Inducing An Immune Response
	7/2/2002	Chemocentryx, Inc.	Assignee	Application Publication	10061944 20020182594	Chemomagnetic retrieval of CMV and CMV infected cells Chemomagnetic retrieval of CMV and CMV infected cells
	5/24/2002	Chemocentryx, Inc.	Assignee	Application Publication Patent	10061943 20020176870 6740324	Methods And Compositions Useful For Stimulating An Immune Response Methods And Compositions Useful For Stimulating An Immune Response Methods And Compositions Useful For Stimulating An Immune Response
	5/23/2002	Chemocentryx, Inc.	Assignee	Application Publication	09975567 20020132836	Compounds and methods for modulating CCR4 function Compounds and methods for modulating CCR4 function
	5/20/2002	Chemocentryx, Inc.	Assignee	Application Publication	09944163 20020127544	Modulators of US 28 Modulators of US 28
	5/8/2002	Chemocentryx, Inc.	Assignee	Application Publication	09944051 20020193374	Reagents and methods for the diagnosis of CMV dissemination Reagents and methods for the diagnosis of CMV dissemination
	2/25/2002	Chemocentryx, Inc.	Assignee	Application Publication Patent	09944049 20030175681 7025968	Cmv Vaccines Cmv Vaccines Cmv Vaccines
	2/6/2002	Chemocentryx, Inc.	Assignee	Application Publication	09919224 20020197234	Immunologic activities of rhesus cytomegalovirus encoded IL-10 and human... Immunologic activities of rhesus cytomegalovirus encoded IL-10 and human...
	1/2/2002	Chemocentryx, Inc.	Assignee	Application Publication	09839445 20020071825	Methods and compositions for inducing an immune response Methods and compositions for inducing an immune response
	4/20/2001	Chemocentryx, Inc.	Assignee	Application Patent	09721908 6699677	Tethered Ligands And Methods Of Use Tethered Ligands And Methods Of Use
	2/24/1997	Schering Corporation	Assignee	Application Patent	08649006 6548654	Dna Encoding Mammalian Cx3c Chemokine Genes Dna Encoding Mammalian Cx3c Chemokine Genes
	4/1/1996	Schering Corporation	Assignee	Application Patent	08567882 6512103	Mammalian Chemokine Reagents Mammalian Chemokine Reagents

34 Rows Total

Schall, Thomas J. has not been involved in any trademark assignment transactions in the PlainSite database.

Affiliated Entities

• Chemocentryx, Inc.
• Immuneering Corp

Incoming Payments

This individual has not disclosed any incoming payments from lobbying groups.

Outgoing Payments

This individual has not disclosed any outgoing payments to lobbying groups.